Nature4 个月
B-cell-depletion therapy in SLE—what are the current prospects for its acceptance?
Moreover, quantifiable levels of serum B-cell-activating factor (BAFF, also known as BLyS and tumor necrosis factor ligand superfamily, member 13b) before rituximab treatment correlated ...
Nature9 年
Translating the effects of BAFF in SLE
Belimumab, a humanized antibody against B-cell-activating factor (BAFF, also known as BLyS and tumor necrosis factor ligand superfamily, member 13b) has been hailed as a promising new agent for ...